Roivant Sciences Ltd
ROIV
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.15B
Close$
$1.85
94.9% downside
Current Fair Value
94.9% downsideOvervalued by 94.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.15 Billion |
|---|---|
| Enterprise Value | $25.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.43 |
| Beta | 1.13 |
| Outstanding Shares | 720,776,739 |
Return
| Return on Equity | -6.29% |
|---|---|
| Return on Assets | -5.02% |
| Return on Invested Capital | -22.85% |
Valuation & Multiples
| P/E Ratio | -95.26 |
|---|---|
| PEG | 634.69 |
| Price to Sales | - |
| Price to Book Ratio | 6.05 |
| Enterprise Value to Revenue | 3330.32 |
| Enterprise Value to EBIT | -21.85 |
| Enterprise Value to Net Income | -95 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$2.07 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$3.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.9854▲ 23.01% |
|---|---|
| Total Calls | 27,400▼ 97.95% |
| Total Puts | 27,000▼ 97.32% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.67%▼ 60.84% |
|---|---|
| Total Invested | $3.60B▼ 75.45% |
| Investors Holding | 221▼ 242.00% |
ESG Score
No data